Matteo Levisetti
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matteo Levisetti
Cue Biopharma, Inc. reported in an 8-K filed November 20, 2025 that Matteo Levisetti was terminated as Chief Medical Officer, effective November 28, 2025. The proxy statement of Cue Biopharma, Inc. reports total compensation of $1,219,364 for Matteo Levisetti in fiscal 2025, including a base salary of $470,753. Disclosed compensation is on record for 2 fiscal years.
“On November 17, 2025, Cue Biopharma, Inc. (the "Company") and Matteo Levisetti, Chief Medical Officer, agreed that Dr. Levisetti's employment with the Company will terminate effective November 28, 2025 (the "Separation Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cue Biopharma, Inc. (CUE)
Proxy statement
Start not stated–2025-11-28
-
Cue Biopharma, Inc. (CUE)
Proxy statement
Start not stated–2025-11-28
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cue Biopharma, Inc. (CUE) | Former Chief Medical Officer | $470,753 | $1,219,364 |
| 2024 | Cue Biopharma, Inc. (CUE) | Former Chief Medical Officer | $478,217 | $1,191,276 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.